Clostridium difficile diagnostika. Paul Naaber

Size: px
Start display at page:

Download "Clostridium difficile diagnostika. Paul Naaber"

Transcription

1 Clostridium difficile diagnostika Paul Naaber Paul Naaber

2 Sissejuhatus Grampositiivne anaeroob Moodustab eoseid Virulentsusfaktorid Toksiin A ja B olulised haiguse tekkes binary toxin tähtsus ebaselge Haigus asümptomaatiline seedetrakti kolonisatsioon: 3-5(-50?) % tervetesl täiskasvanutel haiglaväliselt sage (ca 50%) alla 2 aastastel lastel 7-50% hospitaliseeritutest antibiootikumraviga seotud kõhulahtisus (AAD) pseudomembranoosne koliit (PMC) 2

3 3 S. M. Poutanen et al. CMAJ (2004) 171: 51-58

4 Probleemi olulisus CDI juhu hind (13 uuringut, EU, USA, Kanada) esmane haigusjuht USD korduv CDI CD haiglavälise CD infektsiooni osatähtsus suureneb UK: CDAD diagnoosimine perearstide poolt suurenud 1-lt 22 juhuni /100,000 suureneb haigestumus ja komplitseeritud juhtude arv Kanada : sagedus 36-t 156 juhuni ; komplitseeritud juhtude arv 7-lt 18%-ni 4

5 Diagnostika meetodid: sissejuhatus CD produktide määramine Toksiin A ja/või B EIA - A+B» Immuunkromogeensed kiirtestid, well-type ELISA rakukultuur -toksiin B GDH (glutamaat dehüdrogenaas) kultiveerimine CCFA, Brazier s CCEYA, CDMN, chromid CD geenide määramine kommertsiaalsed real-time PCR GeneOhm (Beckton Dickinson): tcdb Xpert (Cephid): tcdb; cdta/cdtb; tcdc-deletion Prodesse ProGastro Cd: tcdb (Meridian Illumigene, Loop-Mediated Isothermal Amplification: tcda) in-house 5

6 Toxin A/B EIA (membrane) Toxin A/B EIA (well-type) GDH EIA (membrane) GDH EIA (welltype) Sensitivity % Range (Mean) (72)# (52)* (82)# (66)* Real-time PCR # 84-86* Specificity% Range (Mean) (98)# (98)* (97)# (98)* Eelised Sobib üksikuteks testideks Kiire, spetsiifiline, parem korrelatsioon kliinilise haigusega (90)# (90)# Sobib üksikuteks testideks (93)# (89)# # 97-98* kiire; kõrge NPV (95-100); sobilik skriininguks Tundlik ja spetsiifiline Puudused Madalam tundlikkus kui külvil; ei saa mikroobi tüve Madalam spetsiifilisus, positiivsed juhud tuleks kinnitada Kallim?; ei saa mikroobi tüve Külv ja tüve toksilisuse test Tundlik ja spetsiifiline; tüvi edasisteks uuringuteks Töö ja ajamahukas, vaja anaeroobse külvi süsteeme Toksiini määramine rakukultuuril Tundlik ja spetsiifiline Töö ja ajamahukas; vaja rakukultuure; ei saa mikroobi tüve # compared with cell culture cytotoxity assay; * compared with toxigenic culture 6

7 (Toksiini) testi tundlikkus sõltub tüvest 7

8 Diagnostika meetodid: soovitused külv (koos tox testiga kultuurist) +/- otsene tox test selektiivne sööde +/- alkohol sokk + tox test CD tüvest tox A+B EIA (rakukultuur) PCR (+/- külv) real-time PCR külv (epidemioloogiline vms vajadus) 2 astmelised algoritmid skriining-test positiivsete juhtude kinnitamine 8

9 CD diagnostika algoritm (näidis) Skriiningtest GDH GDH neg Vasta: CD neg GDH pos Kinnitav test: toksiin (+ külv) (Toks pos: vasta CD pos) Toksiin ja külv neg Vasta: CD neg Toksiin pos (külv pos v. neg) Vasta: CD pos Toksiin neg ja külv pos Määra toksiin CD tüvel Toksiin pos tüvi Vasta: CD pos Toksiin neg tüvi Vasta: CD neg 9

10 proovide säilitamine Proovivõtt C. difficile vegetatiivsed rakud ja eosed - külviks temp suurt ei mõjuta, hulgad stabiilsed päevi (nädalaid) CD toksiinid EIA testiks +4 C stabiilne päevi (nädalaid) -20 C ja (mitmed) külmutus/sulatus tsüklid vähendavad tundlikkust oluliselt 10

11 Näidustused EI ole näidustatud asümptomaatiliste patsientide skriining reeglina EI ravi kontrolli uuringud - reeglina EI (kuni 30% jäävad CD pos) mitte-vedela väljaheite uuringud - EI ON näidustatud kõik hospitaliseeritud patsiendid (>3d) kellel kõhulahtisus (sõltumata uuringu tellimisest)? haiglavälised patsiendi AB kõhulahtisusega? Epidemioloogilistel näidustustel AB tundlikkuse testimine tüpiseerimine 11

12 Infektsioon v kolonisatsioon? mida tundlikumad testid, seda enam avastame ka kolonisatsiooni kolonisatsioon + kõhulahtisus muust mehhanismist (patogeenist) 44 99% of AAD pole CD põhjustatud 7-50% haiglapatsientidest on CD-ga koloniseeritud seega, CD kolonisatsioon ja non-cd kõhulahtisus on võimalik kokkusattumus kas lab saab neid juhtumeid eristada? muud põletiku markerid: PMN; lactoferrin test pole spetsiifilised ega tundlikkud toksiini esinemine sooles viitab tõelisele infektsioonile? pole kindel marker 12

13 mild CDI vs. severe CDI: fecal toxin level 13

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose?

Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist

More information

Clostridium difficile Testing Algorithms Using Glutamate Dehydrogenase Antigen and C.

Clostridium difficile Testing Algorithms Using Glutamate Dehydrogenase Antigen and C. JCM Accepts, published online ahead of print on 18 January 2012 J. Clin. Microbiol. doi:10.1128/jcm.05620-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 Clostridium difficile

More information

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015

DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015 DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News Volume 3, Number 6, June 2015 Diagnostic Testing for Clostridium difficile Infection Background Clostridium difficile

More information

Laboratory diagnosis of Clostridium difficile infection

Laboratory diagnosis of Clostridium difficile infection Review Article Page 1 of 5 Laboratory diagnosis of Clostridium difficile infection Katherine Kendrick Mercer University School of Medicine (SOM), Navicent Health, Macon, GA, USA Correspondence to: Katherine

More information

Rapid and Sensitive Loop-Mediated Isothermal Amplification (LAMP) Test for. Gold Standard

Rapid and Sensitive Loop-Mediated Isothermal Amplification (LAMP) Test for. Gold Standard JCM Accepts, published online ahead of print on 24 November 2010 J. Clin. Microbiol. doi:10.1128/jcm.01824-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

on November 8, 2018 by guest

on November 8, 2018 by guest JCM Accepts, published online ahead of print on December 00 J. Clin. Microbiol. doi:./jcm.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

EVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN )

EVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN ) EVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN ) Delefortrie Quentin Intern in Clinical Pathology Corata, 20-21 September 2018 Presentation Plan Evaluation of the cobas Liat Influenza

More information

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)

Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and

More information

"QUIK CHEK"[tw])) NOT ((therapy[ti] OR treatment[ti] OR treat*[ti]) NOT (diagnosis[ti] OR

QUIK CHEK[tw])) NOT ((therapy[ti] OR treatment[ti] OR treat*[ti]) NOT (diagnosis[ti] OR Supporting information Appendix 1: Search strategy Pubmed (("Clostridium Infections/diagnosis"[majr] AND "Clostridium difficile"[majr]) OR (((("Clostridium difficile"[majr] OR "Clostridium Difficile"[ti])

More information

Jen KOK*, Qinning WANG, Lee C THOMAS, Gwendolyn L GILBERT. Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of

Jen KOK*, Qinning WANG, Lee C THOMAS, Gwendolyn L GILBERT. Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of JCM Accepts, published online ahead of print on 17 August 2011 J. Clin. Microbiol. doi:10.1128/jcm.00752-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

JMSCR Vol 05 Issue 07 Page July 2017

JMSCR Vol 05 Issue 07 Page July 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.15 Rapid Diagnosis of Toxigenic Clostridium

More information

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections

Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections Washington University School of Medicine Digital Commons@Becker Open Access Publications 2011 Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections Erik

More information

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility Gerald A. Capraro, Ph.D., D(ABMM) Director, Clinical Microbiology Carolinas Pathology Group Atrium

More information

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection

Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection Christopher R. Polage, MD, MAS Associate Professor of Pathology and Infectious Diseases UC Davis Disclosures Test materials

More information

C. DIFF QUIK CHEK COMPLETE. Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE NEXT PAGE

C. DIFF QUIK CHEK COMPLETE. Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE NEXT PAGE C. DIFF QUIK CHEK COMPLETE Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE PAGE CLINICIAN Would actionable C. difficile test results in less than 30 minutes improve patient

More information

The Bristol Stool Scale and Its Relationship to Clostridium difficile Infection

The Bristol Stool Scale and Its Relationship to Clostridium difficile Infection JCM Accepts, published online ahead of print on 16 July 2014 J. Clin. Microbiol. doi:10.1128/jcm.01303-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 The Bristol Stool Scale

More information

Clostridium difficile: An Overview

Clostridium difficile: An Overview Clostridium difficile: An Overview CDI Webinar July 11, 2017 PUBLIC HEALTH DIVISION Acute and Communicable Disease Prevention Section Outline Background Microbiology Burden Pathogenesis Diagnostic testing

More information

Evaluation of BD GeneOhm CDiff PCR Assay for Diagnosis of Toxigenic Clostridium difficile Infection

Evaluation of BD GeneOhm CDiff PCR Assay for Diagnosis of Toxigenic Clostridium difficile Infection Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 7-27-2010 Evaluation of BD GeneOhm CDiff PCR Assay for Diagnosis of

More information

! MQ is a 44 year old woman that I first saw in Sept ! In MVA in Jan 2003 requiring spinal surgery

! MQ is a 44 year old woman that I first saw in Sept ! In MVA in Jan 2003 requiring spinal surgery Case MQ is a 44 year old woman that I first saw in Sept 2006 UPDATE ON CLOSTRIDIUM DIFFICILE DISEASE Richard A. Jacobs, M.D.,PhD In MVA in Jan 2003 requiring spinal surgery Subsequently developed fecal

More information

The disease formerly called Clostridium difficile associated

The disease formerly called Clostridium difficile associated Improving Patient Care Annals of Internal Medicine Does My Patient Have Clostridium difficile Infection? Lance R. Peterson, MD, and Ari Robicsek, MD Clostridium difficile infection (CDI) seems to be changing

More information

Clostridium difficile infection: New Zealand perspective

Clostridium difficile infection: New Zealand perspective Clostridium difficile infection: New Zealand perspective Dr Sally Roberts Clinical Head of Microbiology, ADHB Clinical Lead for the IP&C Programme, HQ&SC Introduction Historical Laboratory diagnosis Survey

More information

S (15) DOI: doi: /j.diagmicrobio Reference: DMB 13832

S (15) DOI: doi: /j.diagmicrobio Reference: DMB 13832 Accepted Manuscript A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype-027 strain with reduced susceptibility to vancomycin and metronidazole

More information

SC P. on POOP. Susan E. Sharp, Ph.D., DABMM Director of Microbiology Portland, OR

SC P. on POOP. Susan E. Sharp, Ph.D., DABMM Director of Microbiology Portland, OR The Straight SC P on POOP Susan E. Sharp, Ph.D., DABMM Director of Microbiology Portland, OR 97230 susan.e.sharp@kp.org But FIRST - - Quiz time! But FIRST - - Quiz time! Here s the QUIZ 4 Here s the QUIZ

More information

INFECTION WITH TOXIN A-NEGATIVE, TOXIN B-NEGATIVE, BINARY TOXIN- POSITIVE CLOSTRIDIUM DIFFICILE IN A YOUNG PATIENT WITH ULCERATIVE COLITIS

INFECTION WITH TOXIN A-NEGATIVE, TOXIN B-NEGATIVE, BINARY TOXIN- POSITIVE CLOSTRIDIUM DIFFICILE IN A YOUNG PATIENT WITH ULCERATIVE COLITIS JCM Accepted Manuscript Posted Online 9 September 2015 J. Clin. Microbiol. doi:10.1128/jcm.01810-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13

More information

Infektsioon artroskoopia järgselt. Madis Rahu ETOS tüsistuste seminar Eivere

Infektsioon artroskoopia järgselt. Madis Rahu ETOS tüsistuste seminar Eivere Infektsioon artroskoopia järgselt Madis Rahu ETOS tüsistuste seminar Eivere 24.04.2015 Infektsioon artroskoopial Enim esinev artroskoopia komplikatsioon: 0,07 kuni 0,4% kirjanduse andmetel Ainuke põhjus

More information

Protocol for the Scottish Surveillance Programme for Clostridium difficile infection.

Protocol for the Scottish Surveillance Programme for Clostridium difficile infection. National Services Scotland Protocol for the Scottish Surveillance Programme for Clostridium difficile infection. User manual. Version 4.0 Revised January 2017 Health Protection Scotland is a division of

More information

A Pharmacist Perspective

A Pharmacist Perspective Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed

More information

Clostridium difficile Infection (CDI) Guideline Update:

Clostridium difficile Infection (CDI) Guideline Update: Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH A Webinar for HealthTrust Members Professor of Medicine September 24,

More information

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE

EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click

More information

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE

DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE Policy Number: PDS 021 Effective Date:

More information

Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection

Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection Eur J Clin Microbiol Infect Dis (2017) 36:1253 1259 DOI 10.1007/s10096-017-2916-9 ORIGINAL ARTICLE Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium

More information

Clostridium difficile Infection (CDI) Management Guideline

Clostridium difficile Infection (CDI) Management Guideline Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for

More information

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital

Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review pathophysiology, risk factors, prevention, and treatment options of

More information

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg?

Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg? Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg? Disclosures Merck Canada, BD Diagnostics, AMD Medical, Canadian Institute for Health Research Merck Canada, Pfizer OBJECTIVES

More information

Session VIII: Clostridium difficile: Epidemiology

Session VIII: Clostridium difficile: Epidemiology Session VIII: Clostridium difficile: Epidemiology Controversies in Clostridium difficile Infection Epidemiology McDonald, L.C.* Trends of Clostridium difficile Infection in VA Hospitals and Proposed System

More information

Clostridium difficile associated diarrhoea HIV and CD4 count in Malawi

Clostridium difficile associated diarrhoea HIV and CD4 count in Malawi Clostridium difficile associated diarrhoea HIV and CD4 count in Malawi For Transactions: Short Communications - 800 words, 1 table or figure, abstract 100 words, 5 references. Michael BJ Beadsworth, Lauren

More information

C. difficile infection

C. difficile infection C. difficile infection Most common cause of infectious diarrhoea in hospital patients 2 major virulence factors: PaLoc toxin A (an enterotoxin) toxin B (a cytotoxin) 3 rd binary toxin Bartlett JG Clin

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Clostridium difficile an old foe in new clothes. Diagnostics, epidemiology and therapy Torbjörn Norén MD, Ph D Dept. Infectious Diseases & Infection Control Örebro University Hospital, Sweden National

More information

COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS

COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS COMPARISON OF THE PREVALENCE AND GENOTYPIC CHARACTERISTICS OF CLOSTRIDIUM DIFFICILE IN A CLOSED AND INTEGRATED HUMAN AND SWINE POPULATION IN TEXAS A Dissertation by KERI NOELLE NORMAN Submitted to the

More information

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI

3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI L. Clifford McDonald, MD Lance R. Peterson, MD March 27, 2012 1 Potential COI L. Clifford McDonald,

More information

Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection

Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection REVIEW 10.1111/1469-0691.12057 Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection M. H. Wilcox Department of Microbiology, Old Medical School, Leeds Teaching

More information

Pre-Assessment Review: Microbiology, Part 2: Virology. Dr. David Hillyard

Pre-Assessment Review: Microbiology, Part 2: Virology. Dr. David Hillyard Pre-Assessment Review: Microbiology, Part 2: Virology Dr. David Hillyard 1. Mutations or deletions within which gene are associated with the hyper-toxin producing strain of Clostridium difficile? a. tcda

More information

11/14/10. A Modern Plague: Clostridium difficile and Inflammatory Bowel Disease

11/14/10. A Modern Plague: Clostridium difficile and Inflammatory Bowel Disease A Modern Plague: Clostridium difficile and Inflammatory Bowel Disease David G. Binion, M.D. Co-Director, Inflammatory Bowel Disease Center Director, Translational Inflammatory Bowel Disease Research Division

More information

Historical Perspective

Historical Perspective The Diagnosis of C. difficile Infections: Does Molecular Make it More or Less difficile? Stephen M. Brecher Ph.D. VA Boston Health Care System BU School of Medicine The opinions expressed in this presentation

More information

500,000 29,000. New 2015 Data. Lessa et al, N Eng J Med 2015: 34.2% of CDI cases were considered community-acquired

500,000 29,000. New 2015 Data. Lessa et al, N Eng J Med 2015: 34.2% of CDI cases were considered community-acquired Cost-effective Treatment of Clostridium difficile Infection in the ICU Kevin W. Garey, PharmD, MS. Professor and Chair University of Houston College of Pharmacy New 2015 Data 500,000 29,000 Lessa et al,

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author ECDIS-NET: Update on Clostridium difficile epidemiology in Europe 1 E d J. K u i j p e r, S o f i e v a n D o r p a n d D a a n N o t e r m a n s. D e p a r t m e n t o f M e d i c a l M i c r o b i o

More information

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015

L. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015 Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division

More information

C. Difficile Testing Protocol

C. Difficile Testing Protocol C. Difficile Testing Protocol Caroline Donovan, RN, BSN, ONC- Infection Control Practitioner Abegail Pangan, RN, MSN, CIC- Infection Control Practitioner U.S. NEWS & WORLD REPORT 2017 2018 RANKINGS Acute

More information

THE NEW ZEALAND MEDICAL JOURNAL

THE NEW ZEALAND MEDICAL JOURNAL THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244 Mary N De Almeida,

More information

Clostridium difficile: Can you smell the new updates?

Clostridium difficile: Can you smell the new updates? Clostridium difficile: Can you smell the new updates? Sunish Shah, Pharm.D. PGY-2 Infectious Disease Pharmacy Resident Yale-New Haven Hospital sshah1741@mail.usciences.edu Learning objectives Recognize

More information

Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI)

Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI) Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI) The NHS Centre for Evidence based Purchasing (CEP) has published the results of an evaluation of the performance

More information

Clostridium difficile 027, A Southern Hemisphere Perspective Dr. David Hammer, Medlab South, New Zealand A Webber Training Teleclass

Clostridium difficile 027, A Southern Hemisphere Perspective Dr. David Hammer, Medlab South, New Zealand A Webber Training Teleclass Clostridium difficile 027 A Southern Hemisphere Perspective THE PRESS 6 July 2006 Dr. David Hammer Microbiology Registrar Medlab South Canterbury, NZ Total Annual Cost of Nosocomial Infection USA US$ 7

More information

Mitteinvasiivne ventilatsioon kiirabi ja EMO praktikas, ehk morfiinivaba kopsuturse ravi

Mitteinvasiivne ventilatsioon kiirabi ja EMO praktikas, ehk morfiinivaba kopsuturse ravi Mitteinvasiivne ventilatsioon kiirabi ja EMO praktikas, ehk morfiinivaba kopsuturse ravi Arkadi Popov Põhja-Eesti Regionaalhaigla reanimobiil A. Bobrov ja tema aparaat Morfiin ja kopsutuse: kas vennad

More information

Molecular Testing in Infectious Diseases. Objectives 5/9/2014. Implementing Molecular Testing for Infectious Diseases Diagnosis

Molecular Testing in Infectious Diseases. Objectives 5/9/2014. Implementing Molecular Testing for Infectious Diseases Diagnosis Molecular Testing in Infectious Diseases Elizabeth Palavecino, M.D. Director Clinical Microbiology Co-Director Clinical & Translational Mass Spec Center Associate Professor of Pathology Wake Forest School

More information

Indeterminate tcdb using a Clostridium difficile PCR assay: a retrospective cohort study

Indeterminate tcdb using a Clostridium difficile PCR assay: a retrospective cohort study Leis et al. BMC Infectious Diseases 2013, 13:324 RESEARCH ARTICLE Indeterminate tcdb using a Clostridium difficile PCR assay: a retrospective cohort study Open Access Jerome A Leis 1,2*, Wayne L Gold 1,2,

More information

Original Article. Infection Control & Hospital Epidemiology (2019), 1 5 doi: /ice

Original Article. Infection Control & Hospital Epidemiology (2019), 1 5 doi: /ice Infection Control & Hospital Epidemiology (2019), 1 5 doi:10.1017/ice.2018.347 Original Article Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile

More information

Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection? Garvey et al. Antimicrobial Resistance and Infection Control (2017) 6:127 DOI 10.1186/s13756-017-0283-z RESEARCH Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile

More information

What s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington

What s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington What s New for Clostridium difficile 2013 John Lynch MD MPH Harborview Medical Center University of Washington Pathogenic Mechanisms of Diarrhea Toxins: Preformed: S aureus, C perfringens, B cereus Formed

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Polage CR, Gyorke CE, Kennedy MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med. Published online Month XX, 2015. doi:10.1001/jamainternmed.2015.4114.

More information

Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of toxigenic Clostridium difficile in fecal specimens

Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of toxigenic Clostridium difficile in fecal specimens JCM Accepts, published online ahead of print on 26 June 2013 J. Clin. Microbiol. doi:10.1128/jcm.01083-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 1 2 3 4 5 6 7 8 9 10

More information

Los Angeles County Department of Public Health: Your Partner in CDI Prevention

Los Angeles County Department of Public Health: Your Partner in CDI Prevention Los Angeles County Department of Public Health: Your Partner in CDI Prevention Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health dterashita@ph.lacounty.gov

More information

Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008*

Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008* ORIGINAL ARTICLE EPIDEMIOLOGY Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008* S. M. Kotila 1, A. Virolainen 1, M. Snellman 1, S. Ibrahem 1, J. Jalava 2 and

More information

Äge keskkõrvapõletik - kas ravida või mitte. Eda Tamm SA TÜK Lastekliinik Türi 2012

Äge keskkõrvapõletik - kas ravida või mitte. Eda Tamm SA TÜK Lastekliinik Türi 2012 Äge keskkõrvapõletik - kas ravida või mitte Eda Tamm SA TÜK Lastekliinik Türi 2012 Äge keskkõrvapõletik (otiit, otitis media acuta) Euroopas 268 episoodi/1000 lapse kohta aastas * 90% < 2 aastastest lastest

More information

This is a repository copy of Clostridium difficile infection: advances in epidemiology, diagnosis and transmission.

This is a repository copy of Clostridium difficile infection: advances in epidemiology, diagnosis and transmission. This is a repository copy of Clostridium difficile infection: advances in epidemiology, diagnosis and transmission. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/93246/

More information

Sc. boulardii- milles peitub tema tugevus. Merli Špitsmeister Biokeemia ja biotehnoloogia MSc

Sc. boulardii- milles peitub tema tugevus. Merli Špitsmeister Biokeemia ja biotehnoloogia MSc Sc. boulardii- milles peitub tema tugevus Merli Špitsmeister Biokeemia ja biotehnoloogia MSc Soolestiku mikrobioota (mikrofloora) on mitmekülgne ja kompleksne ökosüsteem (Czerucka et al., 2007), mis mängib

More information

Clostridium difficile Infection: Diagnosis and Management

Clostridium difficile Infection: Diagnosis and Management Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,

More information

Clostridium difficile infection in patients with inflammatory bowel disease

Clostridium difficile infection in patients with inflammatory bowel disease Review paper Clostridium difficile infection in patients with inflammatory bowel disease Jacek Czepiel 1, Grażyna Biesiada 1, William Perucki 2, Tomasz Mach 1 1 Department of Gastroenterology, Hepatology

More information

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium

More information

Surveillance and outbreak report

Surveillance and outbreak report Surveillance and outbreak report Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 07 and 176 in different areas of Poland, 011 to 01 H Pituch 1, P Obuch-Woszczatyński

More information

CLOSTRIDIUM DIFFICILE: IMPROVING DIAGNOSIS AND TREATMENT. Joshua T. Watson, M.D. Lowcountry Gastroenterology Associates

CLOSTRIDIUM DIFFICILE: IMPROVING DIAGNOSIS AND TREATMENT. Joshua T. Watson, M.D. Lowcountry Gastroenterology Associates CLOSTRIDIUM DIFFICILE: IMPROVING DIAGNOSIS AND TREATMENT Joshua T. Watson, M.D. Lowcountry Gastroenterology Associates Learning Objectives Recognize patients who are highest risk for C. diff infections

More information

The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review

The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review Infect Dis Ther (2018) 7:39 70 https://doi.org/10.1007/s40121-018-0186-1 REVIEW The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review Thomas V. Riley. Tomomi Kimura Received:

More information

Epstein-Barri ja tsütomegaloviiruse serodiagnostika. Maire Tehvre

Epstein-Barri ja tsütomegaloviiruse serodiagnostika. Maire Tehvre Epstein-Barri ja tsütomegaloviiruse serodiagnostika Maire Tehvre EBV Epstein-Barri viirus e. HHV-4 (Human herpesvirus 4) EBV Herpesviiruste perekonnast. Üks tavalisemaid viirusi inimesel. Esineb kogu maailmas.

More information

Modern approach to Clostridium Difficile Infection

Modern approach to Clostridium Difficile Infection Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research

More information

HEALTHCARE- ASSOCIATED CLOSTRIDIUM DIFFICILE INFECTIONS IN CANADIAN ACUTE- CARE HOSPITALS

HEALTHCARE- ASSOCIATED CLOSTRIDIUM DIFFICILE INFECTIONS IN CANADIAN ACUTE- CARE HOSPITALS HEALTHCARE- ASSOCIATED CLOSTRIDIUM DIFFICILE INFECTIONS IN CANADIAN ACUTE- CARE HOSPITALS SURVEILLANCE REPORT JANUARY 1 st, 2007 TO DECEMBER 31 st, 2012 TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH

More information

Clostridium difficile infection surveillance: Applying the case definition

Clostridium difficile infection surveillance: Applying the case definition Clostridium difficile infection surveillance: Applying the case definition PICNet Conference March 3 rd 2016 Presented by: Tara Leigh Donovan, MSc Managing Consultant (Former Epidemiologist) 1 Disclaimer

More information

Clostridium difficile Infection (CDI)

Clostridium difficile Infection (CDI) 18.09.10 월요집담회 Clostridium difficile Infection (CDI) R4 송주혜 Clostridium difficile infection (CDI) Anaerobic gram (+), spore-forming, toxin(tcda&tcdb)-producing bacillus Transmitted among humans through

More information

SESSION VII CLOSTRIDIUM DIFFICILE: EPIDEMIOLOGY

SESSION VII CLOSTRIDIUM DIFFICILE: EPIDEMIOLOGY SESSION VII Healthcare and Community-Associated Clostridium difficile Infection in North America McDonald, L.C.* Emerging Clostridium difficile Strains in North America 3 Limbago, B.M.* Molecular Epidemiology

More information

REVIEW. Ó 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases

REVIEW. Ó 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases REVIEW Emergence of Clostridium difficile-associated disease in North America and Europe E. J. Kuijper 1, B. Coignard 2 and P. Tüll 3 on behalf of the ESCMID Study Group for Clostridium difficile (ESGCD)*,

More information

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Michel Warny, Jacques Pepin, Aiqi Fang, George Killgore, Angela Thompson,

More information

ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study

ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study ICU-Onset Clostridium difficile Infection in a University Hospital in China: A Prospective Cohort Study Xiaohui Wang 1,2, Lin Cai 3, Rujia Yu 1,2, Wenzhi Huang 4, Zhiyong Zong 1,2,4 * 1 Center of Infectious

More information

Comparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection

Comparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection Comparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection Marcus J. Belger A thesis submitted in partial fulfillment of the requirements for the degree of

More information

Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection

Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C. difficile Infection infection control and hospital epidemiology january 2010, vol. 31, no. 1 original article Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment

More information

IHI Expedition Reducing Clostridium difficile Infections Session 2: Rapid Detection and Isolation

IHI Expedition Reducing Clostridium difficile Infections Session 2: Rapid Detection and Isolation July 9, 2014 These presenters have nothing to disclose IHI Expedition Reducing Clostridium difficile Infections Session 2: Rapid Detection and Isolation Brian Koll, MD Cliff McDonald, MD Diane Jacobsen

More information

Clostridium difficile Update

Clostridium difficile Update Clostridium difficile Update Nicholas Havens MD FACP Chief of Medicine Primary Care Harry S Truman Memorial Veterans Hospital Clinical Assistant Professor of Medicine Infectious Diseases University of

More information

MONDAY, JANUARY 29, 2007

MONDAY, JANUARY 29, 2007 MONDAY, JANUARY 29, 2007 ASPECTS OF ACUTE AND CHRONIC PAIN: Practical lectures and case-scenarios, Sweden Postoperative analgesia and outcome: back to square one, Sweden Extending regional techniques at

More information

C. difficile Infection: How it all comes out

C. difficile Infection: How it all comes out C. difficile Infection: How it all comes out Larry Danziger, Pharm.D. Professor of Pharmacy and Medicine College of Pharmacy University of Illinois at Chicago The speaker has no conflicts to disclose.

More information

Clostridium difficile infections Crappy Options

Clostridium difficile infections Crappy Options Clostridium difficile infections Crappy Options Alexandru Petre David MD Infectious Diseases April 21, 2015 Objectives Microbiology Epidemiology Who is at risk? Pathogenesis Diagnosis Treatment Historical

More information

Clostridium difficile: a healthcare associated infection of unknown significance in adults in sub-saharan Africa.

Clostridium difficile: a healthcare associated infection of unknown significance in adults in sub-saharan Africa. Review: Clostridium difficile: a healthcare associated infection of unknown significance in adults in sub-saharan Africa. Alex Keeley 1, Nick J Beeching 1,2,3, Paul Roberts 4, Alastair Watson 5, Mike Beadsworth

More information

Sherwood L. Gorbach, MD Professor of Public Health, Medicine, and Microbiology Tufts University School of Medicine

Sherwood L. Gorbach, MD Professor of Public Health, Medicine, and Microbiology Tufts University School of Medicine Sherwood L. Gorbach, MD Professor of Public Health, Medicine, and Microbiology Tufts University School of Medicine Chief Scientific Officer, Optimer Pharmaceuticals, Inc. Conflicts: Chief Scientific Officer,

More information

Reference assays for Clostridium difficile infection: one or two gold standards?

Reference assays for Clostridium difficile infection: one or two gold standards? 1 Centre for Infection, Division of Cellular and Molecular Medicine, St George s University of London, Cranmer Terrace, London, UK 2 Microbiology, Leeds Teaching Hospitals and University of Leeds, Old

More information

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister

Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister Li StarFish S.r.l. Via Cavour, 35-20063 Cernusco S/N (MI), Italy Tel. +39-02-92150794 - Fax. +39-02-92157285 info@listarfish.it -www.listarfish.it Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister One

More information

In vivo pathogenicity and sporulation patterns of Clostridium difficile. Natalia Blanco Herrera

In vivo pathogenicity and sporulation patterns of Clostridium difficile. Natalia Blanco Herrera In vivo pathogenicity and sporulation patterns of Clostridium difficile by Natalia Blanco Herrera A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy

More information

APIC NHSN Webinar. May 16, National Center for Emerging and Zoonotic Infectious Diseases

APIC NHSN Webinar. May 16, National Center for Emerging and Zoonotic Infectious Diseases National Center for Emerging and Zoonotic Infectious Diseases APIC NHSN Webinar May 16, 2018 Denise Leaptrot Lindsey Weiner LaTasha Powell Dominique Godfrey Disclosures The following speakers discloses

More information

Clostridium difficile infection (CDI)- what s new in diagnosis and treatment; target of antibiotic stewardship

Clostridium difficile infection (CDI)- what s new in diagnosis and treatment; target of antibiotic stewardship Clostridium difficile infection (CDI)- what s new in diagnosis and treatment; target of antibiotic stewardship Thomas J. Louie, MD, FRCPC Medical Director, IP&C, Calgary Health Region; Professor of Medicine,

More information

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections Christina M. Surawicz, MD 1, Lawrence J. Brandt, MD 2, David G. Binion, MD 3, Ashwin N. Ananthakrishnan,

More information

Updated Clostridium difficile Treatment Guidelines

Updated Clostridium difficile Treatment Guidelines Updated Clostridium difficile Treatment Guidelines Arielle Arnold, PharmD, BCPS Clinical Pharmacist Saint Alphonsus Regional Medical Center September 29 th, 2018 Disclosures Nothing to disclose Learning

More information

Antifibrinolüütikumid-kellele ja. Kristjan Kalling, Põhja-Eesti Regionaalhaigla

Antifibrinolüütikumid-kellele ja. Kristjan Kalling, Põhja-Eesti Regionaalhaigla Antifibrinolüütikumid-kellele ja millal? Kristjan Kalling, Põhja-Eesti Regionaalhaigla 111111 Antifibrinolüütikumid B02A Antifibrinolytics B02AA Amino acids B02AA01 Aminocaproic acid B02AA02 Tranexamic

More information

Emergence of Clostridium difficile-associated disease in Canada, the United States of America and Europe.

Emergence of Clostridium difficile-associated disease in Canada, the United States of America and Europe. Second concept, March 3th, 2006. Emergence of Clostridium difficile-associated disease in Canada, the United States of America and Europe. Background document prepared by dr. Ed. J. Kuijper and dr. Peet

More information

Puukborrelioos Saaremaal

Puukborrelioos Saaremaal Puukborrelioos Saaremaal Ülle Parm 1, 2, Egle Niitvägi 3, Kaido Beljaev 3, Tiiu Aro 4, Evi Aotäht 2, Kai Raska 4, Jevgenia Epštein 4, Marje Oona 5, Irja Lutsar 1 Taust. Puukborrelioosi riskirühmaks on

More information

TITLE OF PRESENTATION

TITLE OF PRESENTATION TITLE OF PRESENTATION Can C. Subtitle difficile of Infection Presentation Rates Be Used to Judge Prevention Success for Hospitals? David P. Calfee, MD, MS Associate Professor of Medicine and Public Health

More information